Rare diseases
Investigational molecules
Locations
Back to Italy920 clinical trials in Treviso, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation
ItalyStudy to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria
ItalyStudy on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults
ItalyStudy on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease
ItalyStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
ItalyStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
ItalyStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
ItalyStudy on the Effectiveness and Safety of Iptacopan for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Switching from Anti-C5 Antibody Treatment
ItalyStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
ItalyStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
ItalyStudy of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
ItalyStudy of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Acute Myeloid Leukemia and Lymphomas, including studies on targeted therapies combined with standard chemotherapy. Research focuses on improving treatment outcomes for various blood cancers.
Advanced therapeutic approaches aim to enhance minimal residual disease control and patient outcomes.
Comprehensive research into ovarian cancer treatments, including studies of maintenance therapies and novel drug combinations. Investigations focus on both recurrent and newly diagnosed cases.
Studies emphasize personalized treatment approaches based on specific genetic markers and disease characteristics.
Groundbreaking research in lung cancer and severe respiratory conditions, including targeted therapies for specific genetic mutations and innovative treatment combinations.
Focus on developing personalized treatment strategies for various lung cancer subtypes and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
